نتائج البحث - "Gevers, T.J."

1

دورية أكاديمية

Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

المؤلفون: van Gerven, N., van Erpecum, K., Ouden, J den, Brouwer, J., Vrolijk, J., Gevers, T.J., Drenth, J., Guichelaar, M., Bouma, G., Schreuder, T.C.M.A., van der Wouden, E.J., Baak, L.C., Stadhouders, P., Klemt-Kropp, M., Verhagen, M., Bhalla, A., Kuijvenhoven, J., Almasio, P., Alvarez, F., Andrade, R., Arikan, C., Assis, D., Bardou-Jacquet, E., Biewenga, M., Cancado, E., Cazzagon, N., Chazouillères, O., Colloredo, G., Cuarterolo, M., Dalekos, G., Debray, D., Robles-Díaz, M., Dyson, J., Efe, C., Engel, B., Ferri, S., Fontana, R., Gatselis, N., Gerussi, A., Halilbasic, E., Halliday, N., Heneghan, M., Hirschfield, G., van Hoek, B., Hørby Jørgensen, M., Indolfini, G., Iorio, R., Invernizzi, P., Jeong, S., Jones, D., Kelly, D., Kerkar, N., Lacaille, F., Lammert, C., Leggett, B., Lenzi, M., Levy, C., Liberal, R., Lleo, A., Lohse, A., Lopez, S. Ines, de Martin, E., McLin, V., Mieli-Vergani, G., Milkiewicz, P., Mohan, N., Muratori, L., Nebbia, G., van Nieuwkerk, C., Oo, Y., Ortega, A., Páres, A., Pop, T., Pratt, D., Purnak, T., Ranucci, G., Rushbrook, S., Schramm, C., Stättermayer, A., Swain, M., Tanaka, A., Taubert, R., Terrabuio, D., Terziroli, B., Trauner, M., Valentino, P., van den Brand, F., Vergani, D., Villamil, A., Wahlin, S., Ytting, H., Zachou, K., Zeniya, M., Colapietro, Francesca, Maisonneuve, Patrick, Lytvyak, Ellina, Beuers, Ulrich, Verdonk, Robert C., van der Meer, Adriaan J., van Hoek, Bart, Kuiken, Sjoerd D., Brouwer, Johannes T., Muratori, Paolo, Aghemo, Alessio, Carella, Francesco, van den Berg, Ad P., Zachou, Kalliopi, Dalekos, George N., Di Zeo-Sánchez, Daniel E., Robles, Mercedes, Andrade, Raul J., Montano-Loza, Aldo J., van den Brand, Floris F., Slooter, Charlotte D., Macedo, Guilherme, Liberal, Rodrigo, de Boer, Ynto S., Lleo, Ana

المصدر: In Journal of Hepatology January 2024 80(1):53-61

View record from ScienceDirect

Full Text via ClinicalKey

Full Text Finder

2

دورية أكاديمية

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

View record in Scopus

3

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease

المساهمون: Internal Medicine, Groningen Kidney Center (GKC), Cardiovascular Centre (CVC)

المصدر: Jama : Journal of the American Medical Association, 320, 19, pp. 2010-2019
JAMA-Journal of the American Medical Association, 320(19), 2010-2019. American Medical Association
Journal of the American Medical Association, 320(19), 2010-2019
JAMA, 320(19), 2010-2019. AMER MEDICAL ASSOC
Journal of the American Medical Association
Jama : Journal of the American Medical Association, 320, 2010-2019

مصطلحات موضوعية: Nephrology, Male, medicine.medical_treatment, 030232 urology & nephrology, PROGRESSION, 030204 cardiovascular system & hematology, Lanreotide, Kidney, law.invention, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, PASIREOTIDE, Medicine, Outpatient clinic, Single-Blind Method, TOLVAPTAN, Original Investigation, MOUSE KIDNEY, General Medicine, Middle Aged, Polycystic Kidney, Autosomal Dominant, LONG-ACTING SOMATOSTATIN, Treatment Outcome, Female, Somatostatin, Glomerular Filtration Rate, Adult, EXPRESSION, medicine.medical_specialty, Adolescent, Autosomal dominant polycystic kidney disease, Urology, Renal function, Kidney Volume, Peptides, Cyclic, 03 medical and health sciences, Young Adult, Renal Dialysis, LIVER-DISEASE, OCTREOTIDE, Internal medicine, Humans, Dialysis, business.industry, medicine.disease, EFFICACY, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], chemistry, VOLUME, Quality of Life, Renal disorders Radboud Institute for Health Sciences [Radboudumc 11], business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f061ec257f7cd41ff27a101a5407f98
https://doi.org/10.1001/jama.2018.15870

4

دورية أكاديمية

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

View record in Scopus

5

Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patients

المؤلفون: Gevers, T.J., Burger, D.M., Schipper-Reintjes, E., Kooistra, M.P., Richter, C.

المصدر: Netherlands Journal of Medicine, 74, 225-7
Netherlands Journal of Medicine, 74, 5, pp. 225-7

مصطلحات موضوعية: lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::713ec144a83beca3ad719a5a22a5de02
http://hdl.handle.net/2066/172584

6

Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease

المؤلفون: Meijer, E., Drenth, J.P.H., d'Agnolo, H., Casteleijn, N.F., Fijter, J.W. de, Gevers, T.J., Kappert, P., Peters, D.J.M., Salih, M., Soonawala, D., Spithoven, E.M., Torres, V.E., Visser, F.W., Wetzels, J.F.M., Zietse, R., Gansevoort, R.T., DIPAK Consortium

المساهمون: Groningen Kidney Center (GKC), Surgery, Internal Medicine

المصدر: American Journal of Kidney Diseases, 63, 446-55
American Journal of Kidney Diseases
American Journal of Kidney Diseases, 63, 3, pp. 446-55
American Journal of Kidney Diseases, 63(3), 446-455
American Journal of Kidney Diseases, 63(3), 446-455. W B SAUNDERS CO-ELSEVIER INC
American Journal of Kidney Diseases, 63(3), 446-455. W.B. Saunders

مصطلحات موضوعية: Male, PROTEIN, Lanreotide, THERAPY, law.invention, chemistry.chemical_compound, renal disease, Randomized controlled trial, law, kidney volume, Clinical endpoint, Medicine, cyst progression, CYSTOGENESIS, Polycystic liver disease, Middle Aged, Polycystic Kidney, Autosomal Dominant, LONG-ACTING SOMATOSTATIN, Treatment Outcome, Nephrology, Disease Progression, GROWTH, Female, Somatostatin, glomerular filtration rate (GFR), Glomerular Filtration Rate, Adult, medicine.medical_specialty, disease trajectory, Randomization, Adolescent, Injections, Subcutaneous, Urology, Autosomal dominant polycystic kidney disease, Renal function, Antineoplastic Agents, Polycystic kidney disease (PKD), Peptides, Cyclic, Article, Young Adult, quality of life (QoL), LIVER-DISEASE, OCTREOTIDE, ANALOG, Internal medicine, Humans, Dose-Response Relationship, Drug, business.industry, medicine.disease, GENE, MODEL, Clinical trial, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], Endocrinology, chemistry, Quality of Life, Renal disorders Radboud Institute for Health Sciences [Radboudumc 11], somatostatin analog, business, Follow-Up Studies